Schonfeld Strategic Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Schonfeld Strategic Advisors’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$551K	Buy	+1,932	New	+$569K	﹤0.01%	1771
2025 Q2	–	Sell	-51,521	Closed	-$14M	–	2674
2025 Q1	$14M	Buy	+51,521	New	+$12M	0.08%	236
2022 Q3	–	Sell	-7,699	Closed	-$1.25M	–	3212
2022 Q2	$1.25M	Buy	+7,699	New	+$1.2M	0.01%	921
2021 Q4	–	Sell	-4,600	Closed	-$1.67M	–	2610
2021 Q3	$1.67M	Sell	4,600 -25,926	-85%	-$8.48M	0.02%	776
2021 Q2	$10.5M	Buy	+30,526	New	+$10.1M	0.11%	277
2021 Q1	–	Sell	-15,700	Closed	-$4.06M	–	2170
2020 Q4	$4.06M	Buy	+15,700	New	+$4.32M	0.05%	447
2020 Q3	–	Sell	-6,339	Closed	-$1.19M	–	1723
2020 Q2	$1.19M	Buy	+6,339	New	+$1.03M	0.03%	562
2020 Q1	–	Sell	-1,813	Closed	-$301K	–	1589
2019 Q4	$301K	Buy	+1,813	New	+$301K	0.01%	965

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Schonfeld Strategic Advisors's ONC Position: Q2 2026 in Review

Schonfeld Strategic Advisors opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 1,932 shares worth $551K. The stake represents ﹤0.01% of the portfolio and ranks #1771 among its holdings. This is a return to the name: Schonfeld Strategic Advisors previously reported a position in ONC as recently as Q1 2025.

Schonfeld Strategic Advisors first reported a position in ONC in Q4 2019 and has held it in 8 quarters since. The position peaked at $14M in Q1 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

Schonfeld Strategic Advisors held 1,932 shares of BeOne Medicines Ltd worth $551K as of Q2 2026.
BeOne Medicines Ltd was a new Schonfeld Strategic Advisors position in Q2 2026.
BeOne Medicines Ltd made up ﹤0.01% of Schonfeld Strategic Advisors's portfolio in Q2 2026, its #1771 holding.
Schonfeld Strategic Advisors first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 8 quarters since.
Schonfeld Strategic Advisors's BeOne Medicines Ltd position peaked at $14M in Q1 2025.
283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.